Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets open in 5 hours 27 minutes

S&P Futures
3,914.25
-57.50(-1.45%)
Dow Futures
31,534.00
-305.00(-0.96%)
Nasdaq Futures
11,776.25
-259.00(-2.15%)
Russell 2000 Futures
1,769.40
-22.40(-1.25%)
Crude Oil
109.22
-1.07(-0.97%)
Gold
1,855.50
+7.70(+0.42%)

Advertisement

Entasis Therapeutics Holdings Inc. (ETTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

2.1800

+0.3800

(+21.11%)

At close: 04:00PM EDT

2.1700

-0.01

(-0.46%)

After hours:

07:18PM EDT

Advertisement

L
https://www.marketwatch.com/press-release/ettx-stock-alert-halper-sadeh-llp-is-investigating-whether-the-sale-of-entasis-therapeutics-holdings-inc-is-fair-to-shareholders-2022-05-23?siteid=nbsh
Neutral
S
Time for the class action suits to flow in. This deal clearly is only good for INVA. This is a bogus deal after being above $3 for as long as it was and dropping after a major announcement last year in only about a month. Clearly foul play.
L
https://endpts.com/at-the-cusp-of-nda-filing-for-lead-antibiotic-astrazeneca-spinout-goes-private-at-a-fraction-of-ipo-price/
Neutral
L
Here is the CV of the CEO of Innoviva;

https://www.linkedin.com/in/pavel-raifeld-cfa-b540472/
Bearish
A
Grrrr...

Well, at least it's above my average buy-in price of ~$2.05. *sigh*

A big win/steal for INVA; a big loss/stolen opportunity for the rest of us.
A
Finally, at least a mention of the INVA 'offer' in the 8-K released today reporting on Q1: "...The Board of Directors of Entasis, which does not include any members appointed by or affiliated with Innoviva, has retained MTS Health Partners, L.P. and Covington & Burling LLP to explore alternatives and to assist the board of directors in its evaluation of the proposal consistent with its fiduciary duties."

Here's hoping that they really, truly, keep those final two words of that statement in the forefront of their minds as this process unfolds.
D
Just say no.
L
https://www.marketwatch.com/press-release/shareholder-alert-weiss-law-investigates-entasis-therapeutics-holdings-inc-2022-05-23?siteid=nbsh
Neutral
D
CARB X gets $370 MILLION
A
So tomorrow, the 15th, will mark one solid month from the notification that INVA was willing to, ahem, "sweeten the pot" by raising its offer from $1.80 to $2.00. Not only has the share price refused to even rise up to meet that new level, but I haven't heard one peep from management about any of this...not the original offer, not the revised offer...anything! Anyone else heard anything? An obscure, low-key press release on a third-tier platform, a rumor on the street corner, anything at all? Either something is being negotiated in the background such that nothing can yet be disclosed publicly, or the folks that are supposed to be steering the ship are either asleep at the helm, or drunk in the galley.
h
hahahaha;; the government is steeling all your money!!!
s
How many times shareholders look back and wish they took the offer .
CMTL turned down 30 cash now 12
Bally no to 38
Now low 20’ s
Etc et.
1
Hold strong, way more upside than $2…
1
Just Say No!
A
From a newly released SEC filing (SC 13D/A): "On March 15, 2022 INVA revised its non-binding offer to acquire the Issuer to increase the purchase thereunder to $2.00 per share in cash. All other terms of the offer remain unchanged. The foregoing description of the revised Proposal is qualified in its entirety by reference to the full text of the communication from INVA to the Issuer, a copy of which is attached hereto as Exhibit 16 and is incorporated herein by reference."

Ha, really INVA? That's your idea of 'sweetening the deal'? Keep going...what say you at least triple that, and then we'll talk.
M
measly 100 shares in the 1st hour...just no interest until updates/news from management, I guess.
Neutral
W
When your institutional holdings is 10% total of float and your biggest tute holds 2%, that is a signal and always was. This enterprise or whatever you want to call it... is littered with conflicts of interest and should be a case study for corporate malfeasance and abuse of common stockholders.
L
I think the MINIMUM price should be 3.88 which is the 52 week High and will make sure that those who bought in last year will not lose. Why the F should we have supported the company and end up with NOTHING or a loss even ?. It is grossly abusive.
Neutral
T
Where are the other potential buyers? How about INVA has contacted the other potential buyers and said, "Hey, let us buy ETTX for super cheap and then we will turn around and sell it to you cheaper than trying to buy it on your own. " This is nothing but fraud because, where are the other potential buyers?? You mean to tell me at $2 a share nobody else has thought, "we can offer better than that"???. That tells me that INVA has shareholders by the balls and their plan is too get ETTX for cheap and then flip it for two or three times that in a year. I am seriously think that $2.50 is about as high as they are gonna get.
L
"Entasis Therapeutics stock price target cut to $1.80 from $9.00 at Wedbush "

WHAT, apart from the $1.80 buyout offer, could have caused such a drastic cut in price target ? .

STRANGE.
Neutral